The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Join us to hear an update on the progress of the CF Foundation’s Infection Research Initiative since its launch in 2019 and learn where the strategic vision is headed in the future. You will also learn more about the therapeutic development industry portfolio and exciting happenings in both clinical and basic research areas.
Speaker(s):
Tiffany
Burnett,
Senior Director, Biopharma Programs,
Cystic Fibrosis Foundation
JP
Clancy,
MD,
Senior Vice President of Clinical Research,
Cystic Fibrosis Foundation
You must be logged in and own this session in order to
post comments.
